Clinical Endocrinology Update 2024 Session Recordings

  • Member: ${{salemember}}
  • In-Training Member: ${{salestudent}}
  • Nonmember: ${{salenonmember}}
  • Member: ${{member}}
  • In-Training Member: ${{student}}
  • Nonmember: ${{nonmember}}
Add to Cart {{inStockText}}

Enhance your expertise in hormone health with the Clinical Endocrinology Update 2024 Session Recordings. This essential resource provides six hours of high-impact content from this year’s online meeting, equipping you with insights designed for real-world application and advancing patient care.

Details

Program Highlights

Thirty-six expertly led sessions across nine critical focus areas provide an extensive, specialized learning experience that aligns with current trends in endocrine care. You will gain insights from top experts in the field, positioning yourself at the forefront of hormone health advancements.

  • Case-Based Learning: Practical solutions directly from leading clinicians and real-life case discussions.
  • Engagement with Experts: Access recorded question and answer sessions for deeper insight into patient care strategies.
  • Diverse Specialties: Deepen your knowledge across multiple endocrine fields, enhancing your approach to patient health.

36 Key Topics:

Adrenal

    • Secretory vs Silent Paragangliomas - Treatment Approaches(S12) Immune Checkpoint Inhibitors - Related Endocrinopathies
    • Primary Aldosteronism - Complex Testing vs Empiric Therapy
    • Adrenal Insufficiency – Test Selection


    Bone and Calcium

    • Management of Vertebral Fragility Fractures in Clinical Practice
    • Bone Health Optimization in Special Populations: Cancer and Transplant
    • Defining Success or Failure in Osteoporosis Treatment
    • Osteoporosis Management in Chronic Kidney Disease


    Diabetes

    • New Medications and Updates for the Prevention of Type 1 Diabetes
    • Therapeutic Inertia in Diabetes Management
    • Safe Exercise Strategies for Those with Diabetes
    • Year-In-Diabetes: Review of High Impact Studies, 2023
    • Type 2 Diabetes and its Remission Due to Strict Lifestyle. Does it Exist?
    • Updates from the Field of Cell Therapy in Diabetes


    Female and Male Reproduction

    • Management of PCOS: An Update
    • Female Infertility and Subfertility: Role of Endocrinologist
    • Comprehensive Approach to Male Infertility and Subfertility: Endocrinological and Surgical Perspectives
    • Update on Erectile Dysfunction and Treatment Options


    Lipids and Obesity

    • Genetics in Obesity
    • Post-Bariatric Surgery - Follow-up and Management
    • Food is Medicine: Integrating Nutrition into Healthcare
    • (Heart Association Risk Factor Calculators
    • Therapeutic Options in Obesity: Drugs vs Surgery


    Pituitary Health

    • Updates in Growth Hormone Replacement in Adults
    • Medical Management of Acromegaly
    • Medical Management of Cushing’s Syndrome: Trials and Tribulations
    • Bilateral Inferior Petrosal Sinus Sampling (BIPSS) in the Differential Diagnosis of Patients with ACTH-Dependent Cushing’s Syndrome: Pearls and Pitfalls
    • Neoplastic vs Non-neoplastic Hypercortisolism in Cushing's Syndrome


    Thyroid Conditions

    • Challenging Thyroid Function Tests
    • Thyroid Nodule Tumor Board: Panel Review of Challenging Cases
    • Thyroid Nodules: Diagnosis and Management Using Current Guidelines
    • Hyperthyroidism
    • Thyroid Cancer Tumor Board Panel Discussion


    Transgender Care

    •  Long-Term Management of Transgender and Gender Diverse Adults: The Role of Endocrinologists in Holistic Care


    Clinical Advocacy Session

Earn Continuing Education Credits as You Learn

Maximize your educational time with CEU Session Recordings, earning up 27 AMA PRA Category 1 Credits with flexible, on-demand access. Additionally, you can claim credits at your own pace and on your schedule.

A Seamless Learning Experience

Engage in learning that suits your schedule. These recordings are available on iPhone, iPad, or Android devices with features tailored for an uninterrupted learning experience:

  • Flexible Playback: Download audio or view synchronized slides for learning on demand.
  • Streamlined Search: Locate sessions by topic, title, or presenter with ease.
  • Complete Certification: Each session is accredited by the Endocrine Society, meeting the highest standards in medical education.

Stay at the leading edge of endocrine care. Earn valuable credits, streamline your learning, and bring the latest clinical knowledge directly into your practice with Clinical Endocrinology Update 2024 Session Recordings.

Accreditation You Can Rely On

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Every Clinical Endocrinology Update 2024 session meets the highest standards, ready to help you bring the latest in hormone health directly into your practice. Additionally, the Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit 
The Endocrine Society designates each activity in this course for a maximum of 27 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field. 
 
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body. 

AMA PRA Category 1 Credits™, for the activities related to this material must be claimed by December 31, 2026.

Faculty and Disclosures  

STATEMENT OF INDEPENDENCE  
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Clinical Endocrinology Update Steering Committee.  
 
DISCLOSURE POLICY
The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners of any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following CEU Committee Members reported relevant financial relationships:

  • Sara Ahmadi, MD: Editorial Board: American Thyroid Association Editor: Endocrine Connection Journal; Research Support: Veraycyte.
  • Christine Burt Solorzano, MD:Research Support: Takeda; Grantee: NIH NICHD, Helmsley Trust; Trial Support: Pathway to Prevention
  • Anders L. Carlson, MD: Medical Director: Bright Health Group; Research Investigator: Insulet, Medtronic, Abbott, Dexcom, Sanofi, Novo Nordisk, Eli Lilly, UnitedHealth; Consulting/Advisory Board: Medtronic.
  • Matthew T. Drake, MD, PhD: Author: UpToDate.
  • Leonor Corsino, MD, MHS: Advisor: Latino Medical Student Association; Writing: American Board of Internal Medicine; Advisory Board: Project Access of Durham County, North Carolina Advisory Council; Consultant: GLG.
  • Adina Turcu, MD, MS: Grant: NIH (NIDDK, NHLBI), DDF; Investigator: CinCor; Writer: Endocrine Self-Assessment Program; Editor: JCEM Case Report.
  • Marcel Bartholomeus Twickler, MD, PhD: Working Group: "Health and Nutrition" in the "Hoge gezondheidsraad/Conseil Superieur de la Sante"; Investigator: PATRO Study; Editor: European Journal Clinical Investigation.

The following CEU steering committee members reported no financial relationships: 

  • Shaishav Dhage, MBBS, DNB(Medicine), MRCP, MD; Elizabeth Harris, MD; and Beth Tupta, NP-C.

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships. 
The relevant financial relationships listed for these individuals have been mitigated and there are no other relevant financial relationships with ineligible companies for those with the ability to control the content for this activity. 

Content Licensing
Contact us to learn more about licensing solutions for your organization.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.